(39) quantitatively analysed the methylation of KAZALD1 (Kazal Type Serine Peptidase Inhibitor Domain 1), TMEM308 (Tumor Microenvironment of Metastasis 308), and MAPK13 (Mitogen-Activated Protein Kinase 13) and reported hypermethylation of these genes in PM. The gene discussed is MAP3K13; the disease is neoplasm.